CSPC 2021 has ended
avatar for John D. Lewis

John D. Lewis

Founder, President and Chief Executive Officer

Dr. Lewis is the founder and CEO of Entos pharmaceuticals, a start-up Drug Delivery Company incorporated in 2017. He has a long track record of success leading biotechnology companies in the therapeutic and diagnostic spaces. In addition to his entrepreneurship, Dr. Lewis is the Frank and Carla Sojonky Chair in Prostate Cancer Research at the University of Alberta, Edmonton, Alberta. At the University, his research involves cancer diagnostics, non-invasive molecular imaging and targeting of angiogenesis and metastasis using multivalent nanoparticles. He trained at The Scripps Research Institute in La Jolla, CA, developing targeted molecular imaging technologies. Dr. Lewis holds a Ph.D. in biochemistry from the University of Victoria.